How to screen for colon cancer

Annual Review of Medicine

Volumn 49, Issue , 1998, Pages 163-172

  Lieberman, David ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Cost effectiveness; Epidemiology; Fecal occult blood test; Sigmoidoscopy

Indexed keywords

CANCER SCREENING; COLON CANCER; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; HUMAN; MASS SCREENING; OCCULT BLOOD; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY;

EID: 0031980742     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.49.1.163     Document Type: Review

References (29)

1. Winawer SJ, Zauber AG, Ho MN, et al. 1993. Prevention of colorectal cancer by colonoscopic polypectomy. N. Engl. J. Med. 329:1977-81
2. St. John DJB, McDermott FT, Hopper JL, et al. 1993. Cancer risk in relatives of patients with common colorectal cancer. Ann. Intern. Med. 118:785-90
3. Fuchs CS, Giovannucci EL, Colditz GA, et al. 1994. A prospective study of family history and the risk of colorectal cancer. 1994. N. Engl. J. Med. 331:1669-74
4. Winawer SJ, Zauber AG, Gerdes H, et al. 1996. Risk of colorectal cancer in the families of patients with adenomatous polyps. N. Engl. J. Med. 334:82-87
5. 4a. Bell DA, Stephens EA, Castranio T, et al. 1995. Polyadenylation polymorphism in the acetyltransferose 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res. 55:3537-42
6. Mandel JS, Bond JH, Church TR, et al. 1993. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med. 328:1365-71
7. Kronborg O, Fenger C, Olsen J, et al. 1996. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348:1467-71
8. Hardcastle JD, Chamberlain J, Robinson MHE, et al. 1996. Randomised controlled trial of faecal-coocult-blood screening for colorectal cancer. Lancet 348: 1472-77
9. Kewenter J, Brevinge H, Engaras B, et al. 1994. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal can-cer by fecal occult blood testing. Scand. J. Gastroenterol. 29:468-73
10. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. 1993. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J. Natl. Cancer Inst. 85:1311-18
11. Allison JE, Feldman R, Tekawa IS. 1990. Hemoccult screening in detecting colorectal neoplasm: Sensitivity, specificity and predictive value. Ann. Intern. Med. 112:328-33
12. Ahlquist DA, Wiend HS, Moertel CG, et al. 1993. Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using Hemoccult and HemoQuant tests. JAMA 269:1262-67
13. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. 1992. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326:653-57
14. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. 1992. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl. Cancer Inst. 84: 1572-75
15. Lieberman DA, Smith FW. 1991. Screening for colon malignancy with colonoscopy. Am. J. Gastroenterol. 86:946-51
16. Rex DK, Lehman GA, Ulbright TM, et al. 1993. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: Influence of age, gender, and family history. Am. J. Gastroenterol. 88:825-31
17. Foutch PG, Mai H, Pardy K, et al. 1991. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorec-tal cancer in asymptomatic average-risk men. Digest. Dis. Sci. 36:924-28
18. Zarchy TM, Ershoff D. 1994. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gaslroenterology 106:1501-4
19. Grossman S, Milos ML, Tekawa IS, Jewell NP. 1989. Colonoscopic screening of persons with suspected risk factors for colon cancer: II. Past history of colorectal neoplasms. Gastroenterology 96:299-306
20. Spencer RJ, Melton LJ, Ready RL, Ilstrup DM. 1984. Treatment of small colorectal polyps: A population-based study of the risk of subsequent carcinoma. Mayo Clin. Proc. 59:305-10
21. Read TE, Read JD, Butterly LF. 1997. Importance of adenomas 5mm or less in diameter that are detected by sigmoidoscopy. N. Engl. J. Med. 336:8-12
22. Rex DK, Cummings OW, Helper DJ, et al. 1996. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 111:1178-81
23. Lieberman DA. 1995. Cost-effectiveness model for colon cancer screening. Gas-troenterology 109:1781-90
24. Stryker SJ, Wolff BG, Culp CE, et al. 1987. Natural history of untreated colonic polyps. Gastroenterology 93:1009-13
25. Winawer SJ, Zauber AZ, O'Brien MJ, et al. 1993. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N. Engl. J. Med. 328:901-6
26. Atkin WS, Morson BC, Cuzick J. 1992. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N. Engl. J. Med. 326:658-62
27. Lofti AM, Spencer RJ, Ilstrup DM, Melton LJ. 1986. Colorectal polyps and the risk of subsequent carcinoma. Mayo Clin. Proc. 61:337-43
28. Rex DK, Cutler CS, Lemmel GT, et al. 1997. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112: 24-28
29. Wagner JL, Tunis S, Brown M, et al. 1996. Cost-effectiveness of colorectal cancer screening in average-risk adults. In Prevention and Early Detection of Colorectal Cancer, ed. GP Young, P Rozen, B Levin, pp. 321-56. London: Saunders